Home/Filings/4/0001171843-15-001432
4//SEC Filing

Sucampo Pharmaceuticals, Inc. 4

Accession 0001171843-15-001432

CIK 0001365216operating

Filed

Mar 15, 8:00 PM ET

Accepted

Mar 16, 11:51 AM ET

Size

5.2 KB

Accession

0001171843-15-001432

Insider Transaction Report

Form 4
Period: 2015-03-13
Lichtlen Peter
Chief Medical Officer
Transactions
  • Award

    Employee Stock Option (right to buy)

    2015-03-04+44,000225,400 total
    Exercise: $14.82Exp: 2025-03-04Class A Common Stock (44,000 underlying)
Footnotes (1)
  • [F1]The option vests in 4 equal annual installments beginning on March 4, 2016

Documents

1 file

Issuer

Sucampo Pharmaceuticals, Inc.

CIK 0001365216

Entity typeoperating

Related Parties

1
  • filerCIK 0001365216

Filing Metadata

Form type
4
Filed
Mar 15, 8:00 PM ET
Accepted
Mar 16, 11:51 AM ET
Size
5.2 KB